Clinicmed Daniluk Nowak Sp. k.
- Address
- lock Available on a paid plan
Immune System Diseases
The department investigates innovative therapies for immune system diseases, with a strong emphasis on conditions such as rheumatoid arthritis and psoriatic arthritis, aiming to improve joint function and patient quality of life.
- Rheumatoid Arthritis
- Psoriatic Arthritis
- ACPA-Positive Rheumatoid Arthritis
Ongoing work includes evaluating biologic agents, biosimilars, and novel small‑molecule inhibitors to achieve better disease control and reduced long‑term complications.
Musculoskeletal Diseases
Research at the site targets musculoskeletal diseases, focusing on degenerative joint disorders and bone health, including knee osteoarthritis and osteoporosis, to alleviate pain and preserve mobility.
- Knee Osteoarthritis
- Osteoporosis
- Chronic Pain from Osteoarthritis
Studies explore weight‑management strategies, analgesic options, and disease‑modifying treatments that can slow progression and enhance daily functioning.
Nutritional and Metabolic Diseases
The clinic’s portfolio includes trials on nutritional and metabolic diseases, particularly addressing metabolic imbalances such as hyperuricemia associated with gout and excess body weight, with the goal of normalizing biochemical markers and supporting healthy lifestyles.
- Gout‑Associated Hyperuricemia
- Overweight and Obesity
Investigations evaluate uric‑acid‑lowering agents and weight‑reduction interventions that may also lessen joint stress and cardiovascular risk.
Respiratory Tract Diseases
Clinical activity also covers respiratory tract diseases, with a focus on patients suffering from moderate‑to‑severe chronic obstructive pulmonary disease, seeking therapies that reduce flare‑ups and improve lung function.
- Moderate-to-Severe COPD
Trials assess novel inhaled compounds and systemic agents designed to decrease exacerbation frequency and enhance overall respiratory health.
Skin and Connective Tissue Diseases
The department conducts extensive research on skin and connective tissue diseases, including conditions such as plaque psoriasis, atopic dermatitis, palmoplantar pustulosis, and vitiligo, aiming to provide better symptom control and skin restoration.
- Plaque Psoriasis
- Atopic Dermatitis
- Palmoplantar Pustulosis
- Vitiligo
Research evaluates emerging immunomodulators, targeted biologics, and topical formulations to achieve clearer skin and durable remission.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 15 of 49 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 42 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 14 by active trials.
- 1AstraZeneca AB3active
lock +13 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Janssen Cilag International5trials
lock +12 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Clinicmed Daniluk Nowak Sp. k.
lock Showing 1 of 54 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicenter, Randomized, Double-blind, Placebo- controlled, Parallel-group, Dose-ranging Study to Evaluate the Efficacy and Safety of DC-806 in Participants with Moderate to Severe Plaque Psoriasis | Dice Therapeutics Inc. | Phase II | Not Recruiting | Aug 2023 | Mar 2024 |
IMP list
lock Showing 1 of 49 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Azd5004 | 3 | Unknown | — | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.